FIP Development Goal 7 Workforce Element
Globally, we will have:
A patient-centred and integrated health services foundation for workforce development, relevant to social determinants
of health and needs-based approaches to workforce development.
FIP Development Goal 7 Practice Element
Globally, we will have:
A people-centred and integrated health care provision that is based on an interprofessional and cross- setting seamless continuum including pharmacist-delivered professional services.
FIP Development Goal 7 Science Element
Globally, we will have:
Scientific strategies to evaluate expanded professional pharmacy services and programmes, including translational and reverse-translational research.
Developed by the FIP Workforce Development Hub (WDH), the Workforce Reference Guide collates all information, evidence and expertise from FIP to support our members with measuring progress, evaluation, implementation and transformation processes.
Episode 11 of the FIP Development Goals Digital Programme is focused on “advancing integrated services”. The goal visualizes a people-centred and integrated health care provision that is based on an interprofessional and cross-setting seamless continuum including pharmacist-delivered professional services. Through the lenses of pharmaceutical sciences, workforce, education, and practice, this event aims to advance the ideals of integrated service delivery in a way that benefits our patients and lead to improvement of health outcomes.
1. Describe and explain the components of FIP DG 7 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 7 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 7
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence
New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?
Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites. This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.
1) The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.
2) The value of Apology Legislation on medication error resolution, transparency and patient confidence.
3) The value of centralised medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.
4) The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.
– Ema Paulino , Membro do Comité Executivo/ Secretária Profissional da FIP
– Eduardo Tavares, Presidente da Entidade Reguladora Independente da Saúde (ERIS)
– Artur Nhanengue, Diretor dos Serviços Farmacêuticos do Hospital Central de Maputo (HCM) Moderador Santos Nicolau, Bastonário da Ordem dos Farmacêuticos de Angola
The FIP Pharmacy Practice Research SIG (PPR SIG) was created with the main scope of increasing pharmacy practice contributions to global health through the provision of greater access to the latest high-quality international pharmacy practice research. The PPR SIG also aims to cultivate an international forum for the dissemination of quality, international pharmacy practice research for all stakeholders and stimulate communication, discussion, networking, and collaboration between international pharmacy practice stakeholders.
Based on this objective, this PPR virtual summer meeting aims to increase the quality and quantity of pharmacy practice research by exchanging and disseminating information at an international level. New networks and collaborations will be established on major themes for experienced researchers and higher degree students.
The seminar will provide the overview, results and case studies regarding the rapid response of pharmacy education institutions for COVID 19. It will also highlight changes developed during the response to COVID-19 that serve as a template for improved education and practices for the future.
Moderator: Kerstin Wagner
The following FIP programmes of work and structures support the implementation of this Goal:
FIP Board of Pharmaceutical Practice and sections
Non-communicable Diseases Programme